iRhythm Technologies, a leading digital healthcare company specializing in solutions for disease detection, prediction, and prevention, announced that Chief Financial Officer Brice Bobzien will step down, effective August 31, 2024. Bobzien, who has served as CFO since 2022, will continue to support the company in an advisory role into 2025 to ensure a smooth transition. Quentin Blackford, President and CEO of iRhythm, praised Bobzien’s significant contributions to the company’s financial management and strategic development, noting his disciplined approach and operational excellence.
Daniel Wilson, currently Executive Vice President of Corporate Development and Investor Relations, will succeed Bobzien as CFO. Wilson, who joined iRhythm in 2019, has been instrumental in advising the company on its initial public offering and has held various senior roles, including overseeing corporate strategy and investor relations. His extensive background includes positions at Penumbra, J.P. Morgan, and Piper Jaffray, as well as an early career at KPMG. Wilson holds a bachelor’s degree in business administration from California Polytechnic State University at San Luis Obispo. Blackford expressed confidence in Wilson’s ability to lead iRhythm’s finance organization, citing his strategic expertise and industry experience as key assets for the company’s future growth.
